Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion.

× No keyword cloud information.

11 in total

1. [Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes: efficacy, weight control and safety].

Authors: Yufeng Xu; Peili Wu; Weiheng Wen; Hong Chen
Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2019-11-30

Review 2. Novel Anti-glycemic Drugs and Reduction of Cardiovascular Risk in Diabetes: Expectations Realized, Promises Unmet.

Authors: James H Flory; Jenny K Ukena; James S Floyd
Journal: Curr Atheroscler Rep Date: 2016-12 Impact factor: 5.113

3. Preventive and Curative Medical Interventions.

Authors: Jonathan Fuller
Journal: Synthese Date: 2022-03-01 Impact factor: 1.595

4. Long-Term Efficacy and Safety of Empagliflozin Monotherapy in Drug-Naïve Patients with Type 2 Diabetes in Indian Subgroup: Results from a 76-week Extension Trial of Phase III, Double-Blind, Randomized Study.

Authors: Sunil Gupta; Shehla Shaikh; Pooja Joshi; Shraddha Bhure; Viraj Suvarna
Journal: Indian J Endocrinol Metab Date: 2017 Mar-Apr

Review 5. Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy.

Authors: Lakshini Y Herat; Vance B Matthews; P Elizabeth Rakoczy; Revathy Carnagarin; Markus Schlaich
Journal: Int J Endocrinol Date: 2018-07-05 Impact factor: 3.257

Review 6. Useful pharmacodynamic endpoints in children: selection, measurement, and next steps.

Authors: Lauren E Kelly; Yashwant Sinha; Charlotte I S Barker; Joseph F Standing; Martin Offringa
Journal: Pediatr Res Date: 2018-04-18 Impact factor: 3.756

7. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.

Authors: Takayoshi Suga; Osamu Kikuchi; Masaki Kobayashi; Sho Matsui; Hiromi Yokota-Hashimoto; Eri Wada; Daisuke Kohno; Tsutomu Sasaki; Kazusane Takeuchi; Satoru Kakizaki; Masanobu Yamada; Tadahiro Kitamura
Journal: Mol Metab Date: 2018-10-27 Impact factor: 7.422

8. Body Weight Gain and Hyperphagia After Administration of SGLT-2 Inhibitor: A Case Report.

Authors: Hiromi Hamamoto; Mitsuhiko Noda
Journal: Am J Case Rep Date: 2015-12-07

Review 9. Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.

Authors: Fernando Gomez-Peralta; Cristina Abreu; Albert Lecube; Diego Bellido; Alfonso Soto; Cristóbal Morales; Miguel Brito-Sanfiel; Guillermo Umpierrez
Journal: Diabetes Ther Date: 2017-07-18 Impact factor: 2.945

10. Sodium-glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions.

Authors: John A D'Elia; Alissa R Segal; George P Bayliss; Larry A Weinrauch
Journal: Int J Nephrol Renovasc Dis Date: 2017-06-15